262 related articles for article (PubMed ID: 34352427)
21. EIF2α phosphorylation is regulated in intracellular amastigotes for the generation of infective Trypanosoma cruzi trypomastigote forms.
Castro Machado F; Bittencourt-Cunha P; Malvezzi AM; Arico M; Radio S; Smircich P; Zoltner M; Field MC; Schenkman S
Cell Microbiol; 2020 Nov; 22(11):e13243. PubMed ID: 32597009
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in
Barisón MJ; Rapado LN; Merino EF; Furusho Pral EM; Mantilla BS; Marchese L; Nowicki C; Silber AM; Cassera MB
J Biol Chem; 2017 May; 292(21):8964-8977. PubMed ID: 28356355
[No Abstract] [Full Text] [Related]
23. The Trypanosoma rangeli trypomastigote surfaceome reveals novel proteins and targets for specific diagnosis.
Wagner G; Eiko Yamanaka L; Moura H; Denardin Lückemeyer D; Schlindwein AD; Hermes Stoco P; Bunselmeyer Ferreira H; Robert Barr J; Steindel M; Grisard EC
J Proteomics; 2013 Apr; 82():52-63. PubMed ID: 23466310
[TBL] [Abstract][Full Text] [Related]
24. Comparative Analysis of the Secretome and Interactome of
Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
Front Immunol; 2020; 11():1774. PubMed ID: 32973747
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi.
de Hernández MA; Martinez Peralta G; Vena R; Alonso VL
J Vis Exp; 2023 May; (195):. PubMed ID: 37246875
[TBL] [Abstract][Full Text] [Related]
26. Proteomic changes in Trypanosoma cruzi epimastigotes treated with the proapoptotic compound PAC-1.
de Castro Andreassa E; Santos MDMD; Wassmandorf R; Wippel HH; Carvalho PC; Fischer JSDG; Souza TACB
Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140582. PubMed ID: 33285319
[TBL] [Abstract][Full Text] [Related]
27. A dataset of proteins associated with
Márvez ER; Segura CAR; Requena JM; Puerta CJ
Data Brief; 2022 Apr; 41():107953. PubMed ID: 35242934
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of the human pathogen Trypanosoma cruzi.
Paba J; Santana JM; Teixeira AR; Fontes W; Sousa MV; Ricart CA
Proteomics; 2004 Apr; 4(4):1052-9. PubMed ID: 15048986
[TBL] [Abstract][Full Text] [Related]
29.
Ramírez-Toloza G; Ferreira A
Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
[TBL] [Abstract][Full Text] [Related]
30. Trypanosoma cruzi alkaline 2-DE: Optimization and application to comparative proteome analysis of flagellate life stages.
Magalhães AD; Charneau S; Paba J; Guércio RA; Teixeira AR; Santana JM; Sousa MV; Ricart CA
Proteome Sci; 2008 Sep; 6():24. PubMed ID: 18778485
[TBL] [Abstract][Full Text] [Related]
31. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
[TBL] [Abstract][Full Text] [Related]
32. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi.
Chao D; Dusanic DG
Am J Trop Med Hyg; 1985 Jul; 34(4):694-701. PubMed ID: 3927760
[TBL] [Abstract][Full Text] [Related]
34. Interaction of Trypanosoma cruzi with macrophages: effect of previous incubation of the parasites or the host cells with lectins.
de Araújo-Jorge TC; de Souza W
Z Parasitenkd; 1986; 72(2):153-71. PubMed ID: 3085365
[TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi infection changes the chromatin proteome profile of infected human cells.
Florentino PTV; Vitorino FNL; Mendes D; da Cunha JPC; Menck CFM
J Proteomics; 2023 Feb; 272():104773. PubMed ID: 36414228
[TBL] [Abstract][Full Text] [Related]
36. The overexpression of TcAP1 endonuclease confers resistance to infective Trypanosoma cruzi trypomastigotes against oxidative DNA damage.
Valenzuela L; Sepúlveda S; Ponce I; Galanti N; Cabrera G
J Cell Biochem; 2018 Jul; 119(7):5985-5995. PubMed ID: 29575156
[TBL] [Abstract][Full Text] [Related]
37. Trypanosoma cruzi: characterization of an intracellular epimastigote-like form.
Almeida-de-Faria M; Freymüller E; Colli W; Alves MJ
Exp Parasitol; 1999 Aug; 92(4):263-74. PubMed ID: 10425154
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor-like activity isolated from Trypanosoma cruzi.
Gomes MT; Monteiro RQ; Grillo LA; Leite-Lopes F; Stroeder H; Ferreira-Pereira A; Alviano CS; Barreto-Bergter E; Neto HC; Cunha E Silva NL; Almeida IC; Soares RM; Lopes AH
Int J Parasitol; 2006 Feb; 36(2):165-73. PubMed ID: 16337632
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Proteomic Analysis of Replicative and Nonreplicative Forms Reveals Important Insights into Chromatin Biology of Trypanosoma cruzi.
Leandro de Jesus TC; Calderano SG; Vitorino FN; Llanos RP; Lopes MC; de Araújo CB; Thiemann OH; Reis MD; Elias MC; Chagas da Cunha JP
Mol Cell Proteomics; 2017 Jan; 16(1):23-38. PubMed ID: 27852749
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: polypeptide markers of epimastigotes and trypomastigotes.
Rangel-Aldao R; Comach G; Allende O; Cayama E; Delgado V; Piras R; Piras M; Henriquez D; Negri S
Mol Biochem Parasitol; 1986 Jul; 20(1):25-32. PubMed ID: 3090434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
